Aug 1, 2023 07:01AM
Aug 1, 2023 07:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 4, 2022 07:00AM
Aug 4, 2022 07:00AM
May 12, 2022 05:55AM Cantor Fitzgerald Maintains ProQR Therapeutics N.V. (PRQR) at Overweight with $3.50 Price Target
May 5, 2022 04:30PM
May 5, 2022 04:30PM
Apr 26, 2022 04:10PM
Apr 26, 2022 04:10PM
Apr 13, 2022 07:00AM
Apr 13, 2022 07:00AM
Feb 24, 2022 07:00AM ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results
Feb 24, 2022 07:00AM
Feb 11, 2022 07:01AM
Feb 11, 2022 07:00AM
Feb 11, 2022 07:00AM
Jan 4, 2022 07:00AM
Jan 4, 2022 07:00AM
Dec 16, 2021 07:00AM ProQR Announces First Patients Dosed in Phase 2/3 Pivotal Trials of QR-421a for USH2A Mediated Retinitis Pigmentosa
Dec 16, 2021 07:00AM
Nov 18, 2021 04:01PM
Nov 18, 2021 04:01PM
Nov 4, 2021 07:00AM
Nov 4, 2021 07:00AM
Sep 6, 2021 04:15PM
Sep 6, 2021 04:15PM ProQR Announces Virtual Presentation at EURETINA 2021
Aug 5, 2021 07:00AM
Aug 5, 2021 07:00AM
May 6, 2021 07:00AM
May 6, 2021 07:00AM
Apr 23, 2021 07:00AM
Apr 23, 2021 07:00AM
Apr 13, 2021 04:15PM ProQR (PRQR) Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10
Apr 13, 2021 04:15PM
Apr 13, 2021 04:15PM
Apr 2, 2021 04:15PM
Apr 2, 2021 04:15PM
Mar 31, 2021 09:22AM
Mar 30, 2021 05:42PM
Mar 24, 2021 07:04AM ProQR (PRQR) Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials
Mar 24, 2021 07:00AM
Mar 24, 2021 07:00AM
Mar 17, 2021 07:00AM
Mar 17, 2021 07:00AM
Feb 25, 2021 07:00AM
Feb 25, 2021 07:00AM
Feb 16, 2021 04:30PM ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
Feb 16, 2021 04:30PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All